BD partners across all stages of the drug development process, supporting leading biopharmaceutical companies and CROs globally to advance companion diagnostics development programs with cutting edge single-cell technologies/analysis and scientific collaboration from discovery to market approval and commercialization.
Companion Diagnostics (CDx)
BD Biosciences has over 125 years of experience in the medical device market and is on the forefront of using flow cytometry as a CDx modality. Our dedicated team of CDx experts, with global footprint and regulatory experience, is ready to partner with you to develop, validate and position your CDx for a successful day-one launch.
